K. Patel

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.3K citations · Full text

Mendelian Disorder, Genetics, Ivacaftor Combination Regimen +2

Noninvasive monitoring of infection and rejection after lung transplantation

Iwijn De Vlaminck, Lance Martin, Michael A. Kertesz et al. · Proceedings of the National Academy of Sciences · 2015 · 351 citations · Full text

Lung Transplantation, Transplantation, Viral Diagnostics +8

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation

Sean Agbor-Enoh, Yan Wang, Ilker Tunc et al. · EBioMedicine · 2019 · 141 citations · Full text

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 116 citations · Full text

Medicine, Hypertonic Saline, Dornase Alfa +1

Combining Visualization and Statistical Analysis to Improve Operator Confidence and Efficiency for Failure Detection and Localization

Peter Bodík, Michael I. Jordan, David A. Patterson et al. · 2005 · 78 citations · Full text

Software Maintenance, Engineering, Diagnosis +28